Technical Analysis for CTXR - Citius Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 6.39% | |
| Oversold Stochastic | Weakness | 6.39% | |
| MACD Bearish Signal Line Cross | Bearish | 10.71% | |
| Calm After Storm | Range Contraction | 10.71% | |
| Doji - Bullish? | Reversal | 10.71% | |
| Lower Bollinger Band Walk | Weakness | 10.71% |
| Alert | Time |
|---|---|
| Up 5% | 1 day ago |
| 20 DMA Resistance | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Rose Above 20 DMA | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
Get a Trading Assistant
- Earnings date: 06/03/2024
Citius Pharmaceuticals, Inc. Description
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Drugs Inflammation Catheter Antibiotics Cancer Care Care Products Prescription Product Prescription Products Acetamides Bloodstream Infections Lidocaine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.4 |
| 52 Week Low | 0.6 |
| Average Volume | 1,699,883 |
| 200-Day Moving Average | 0.76 |
| 50-Day Moving Average | 0.76 |
| 20-Day Moving Average | 0.68 |
| 10-Day Moving Average | 0.67 |
| Average True Range | 0.06 |
| RSI (14) | 50.00 |
| ADX | 16.3 |
| +DI | 30.24 |
| -DI | 18.28 |
| Chandelier Exit (Long, 3 ATRs) | 0.66 |
| Chandelier Exit (Short, 3 ATRs) | 0.79 |
| Upper Bollinger Bands | 0.74 |
| Lower Bollinger Band | 0.62 |
| Percent B (%b) | 0.66 |
| BandWidth | 18.29 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.02 |
| MACD Histogram | 0.0034 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.77 | ||||
| Resistance 3 (R3) | 0.77 | 0.74 | 0.76 | ||
| Resistance 2 (R2) | 0.74 | 0.72 | 0.74 | 0.76 | |
| Resistance 1 (R1) | 0.72 | 0.71 | 0.73 | 0.72 | 0.75 |
| Pivot Point | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 |
| Support 1 (S1) | 0.67 | 0.67 | 0.68 | 0.67 | 0.64 |
| Support 2 (S2) | 0.64 | 0.66 | 0.64 | 0.64 | |
| Support 3 (S3) | 0.62 | 0.64 | 0.64 | ||
| Support 4 (S4) | 0.62 |
